HomeCompareRCAX vs JNJ

RCAX vs JNJ: Dividend Comparison 2026

RCAX yields 14.60% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RCAX wins by $32.1K in total portfolio value
10 years
RCAX
RCAX
● Live price
14.60%
Share price
$13.70
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52.1K
Annual income
$3,601.12
Full RCAX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RCAX vs JNJ

📍 RCAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRCAXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RCAX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RCAX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCAX
Annual income on $10K today (after 15% tax)
$1,240.88/yr
After 10yr DRIP, annual income (after tax)
$3,060.95/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RCAX beats the other by $2,357.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCAX + JNJ for your $10,000?

RCAX: 50%JNJ: 50%
100% JNJ50/50100% RCAX
Portfolio after 10yr
$36.1K
Annual income
$2,214.45/yr
Blended yield
6.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RCAX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCAX buys
0
JNJ buys
0
No recent congressional trades found for RCAX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRCAXJNJ
Forward yield14.60%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$52.1K$20.0K
Annual income after 10y$3,601.12$827.78
Total dividends collected$24.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RCAX vs JNJ ($10,000, DRIP)

YearRCAX PortfolioRCAX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,160$1,459.85$10,676$355.77+$1.5KRCAX
2$14,670$1,659.03$11,407$389.39+$3.3KRCAX
3$17,568$1,870.57$12,198$426.53+$5.4KRCAX
4$20,891$2,093.48$13,056$467.62+$7.8KRCAX
5$24,680$2,326.64$13,987$513.12+$10.7KRCAX
6$28,976$2,568.81$14,998$563.56+$14.0KRCAX
7$33,823$2,818.69$16,098$619.52+$17.7KRCAX
8$39,266$3,074.94$17,295$681.69+$22.0KRCAX
9$45,351$3,336.21$18,599$750.82+$26.8KRCAX
10$52,126$3,601.12$20,022$827.78+$32.1KRCAX

RCAX vs JNJ: Complete Analysis 2026

RCAXStock

RCAX uses swap agreements and short-dated listed call options to make bullish bets on the share price of Red Cat Holdings, Inc. (RCAT). Red Cat Holdings is a US-based drone technology company providing unmanned aerial systems and related software for military, government, and commercial applications. The fund seeks to maintain daily leveraged exposure equivalent to 200% of the daily percentage change in RCATs price through daily rebalancing. Returns may deviate from the expected 2x if held for longer than a single day due to factors such as volatility, compounding, or rebalancing effects. RCAX may also hold US government securities, money market funds, short-term bond ETFs, and investment-grade corporate debt as collateral for its derivatives positions.

Full RCAX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RCAX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCAX vs SCHDRCAX vs JEPIRCAX vs ORCAX vs KORCAX vs MAINRCAX vs ABBVRCAX vs MRKRCAX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.